AJP - Regulatory, Integrative and Comparative Physiology, Vol 259, Issue 1 38-R44, Copyright © 1990 by American Physiological Society

ARTICLES

Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle

D. Beasley
Evans Memorial Department of Clinical Research, Boston University Medical Center, Massachusetts 02118.

Our recent studies indicate that interleukin 1 (IL-1) and bacterial lipopolysaccharide inhibit agonist-induced contractions in rat aortic rings by an endothelium-independent mechanism. The present study investigated the role of guanosine 3',5'-cyclic monophosphate (cGMP) in the vasodilatory action of IL-1 and endotoxin. Rat aortic rings were denuded of endothelium and incubated for 3 h in physiological salt solution containing no additions, IL-1 (20 ng/ml), or endotoxin (10 micrograms/ml). Contractions induced by phenylephrine (3 x 10(-7) M) were decreased by 40 and 85% in endotoxin- and IL-1-treated rings, respectively. IL-1 increased cGMP content 2.5-fold in the absence of and 5.5-fold in the presence of 3-isobutyl-1-methylxanthine (IBMX). Endotoxin also increased cGMP content in the absence and presence of IBMX (5.5- and 25-fold, respectively). Both IL-1- and endotoxin-induced increases in cGMP occurred 3-4 h after initial exposure. The guanylate cyclase inhibitors, LY 83583 and methylene blue, each abolished IL-1- and endotoxin-induced inhibition of contraction and IL-1-induced production of cGMP. Furthermore, hemoglobin, which binds nitric oxide, completely blocked IL-1-induced increases in cGMP. We conclude that IL-1 and endotoxin inhibit vascular contraction in vitro by increasing aortic cGMP content. Studies with inhibitors suggest IL-1 and endotoxin may induce endothelium-independent production of nitric oxide or another free radical that activates soluble guanylate cyclase.

This article has been cited by other articles:

				W. Wang, E. Zolty, S. Falk, S. Summer, Z. Zhou, P. Gengaro, S. Faubel, N. Alp, K. Channon, and R. Schrier Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1 Am J Physiol Renal Physiol, March 1, 2008; 294(3): F571 - F576. [Abstract] [Full Text] [PDF]

				S. Sasu, A. L. Cooper, and D. Beasley Juxtacrine effects of IL-1{alpha} precursor promote iNOS expression in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1615 - H1623. [Abstract] [Full Text] [PDF]

				C. M. Brophy, L. Knoepp, J. Xin, and J. S. Pollock Functional expression of NOS 1 in vascular smooth muscle Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H991 - H997. [Abstract] [Full Text] [PDF]

				R. F. Lodato, A. R. Khan, M. J. Zembowicz, N. W. Weisbrodt, T. A. Pressley, Y.-F. Li, J. A. Lodato, A. Zembowicz, and F. G. Moody Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1356 - G1362. [Abstract] [Full Text] [PDF]

				D. Beasley COX-2 and cytosolic PLA2 mediate IL-1beta -induced cAMP production in human vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1369 - H1378. [Abstract] [Full Text] [PDF]

				F. S. Lamb and T. J. Barna The endothelium modulates the contribution of chloride currents to norepinephrine-induced vascular contraction Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H161 - H168. [Abstract] [Full Text] [PDF]